Why the study?
Does the brand of point-of-care testing monitor affect the variability of displayed INR in whole blood samples?
Does the brand of point-of-care testing monitor affect the variability of displayed INR in whole blood samples?
Answers are grounded in this paper and cite their sources.
Point-of-care INR monitors exhibit variability primarily due to duplication differences rather than between-instrument differences, with some brands showing wider dispersion than others.
The object was to assess the variability in displayed International Normalised Ratio (INR) between monitors of the same manufacture using whole blood samples from the same subjects. Two brands of monitor, CoaguChek Mini and the TAS PT-NC were tested. 14 instruments of each brand were tested on the same day at the same laboratory by the same operator using identical blood samples to avoid between-centre differences in samples and operator technique. Whole blood samples from two normal donors and four coumarin-treated patients were tested to assess between-instrument variability of INR. Results have been coded. There was a much wider dispersion of INR on Brand B than on Brand A. One Brand A instrument failed to give a result with one of the two whole blood samples from one patient. One Brand B monitor gave an aberrant result with one of the samples from a normal subject. On both brands of monitor, INR variability appeared to be due mainly to duplication differences rather than between-instrument variability on both normal and coumarin whole blood samples.
No takes yet. Share an insight, caveat, or question.
Keown et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: